A comment addresses oral semaglutide versus DPP-4 inhibitors for reducing risk of cognitive impairment in elderly patients with HFpEF and obesity.
Link: /findings/915
None recorded — doctrine links and citations appear here as scans and citation sweeps find them.
External: doi:10.1007/s11739-026-04533-5
Subscribe: calendar of upcoming dates · deadlines feed · all new records · Help · Report a problem
build build 880 · 2bcef25 · 2026-11-18
build 880 · 2bcef25 · 2026-11-18